FAQ : HDFC Pharma and Healthcare Fund - Growth - Direct Plan

HDFC Pharma and Healthcare Fund - Growth - Direct Plan has delivered CAGR and average rolling returns as follows :

1 Year 3 Year 5 Year 9 Year
CAGR(%) 65.28 N/A N/A N/A
Average Rolling Returns(%) N/A N/A N/A N/A

The Current NAV of HDFC Pharma and Healthcare Fund - Growth - Direct Plan is ₹16.12.

It is better to invest in a fund with a longer track record as HDFC Pharma and Healthcare Fund - Growth - Direct Plan cannot be assessed for consistency of out-performance. Funds returns are more likely to be different than its benchmark NIFTY 500 returns, as Funds portfolio is significantly different.

HDFC Pharma and Healthcare Fund - Growth - Direct Plan fund’s expense ratio is 0.94%

The process for redemption is

  • Give a request for redemption of the number of units or the amount you want. The request will be acknowledged.
  • You will get information about the redemption and the NAV at which redeemed.
  • The amount will be deposited in the designated bank account.

The AUM of HDFC Pharma and Healthcare Fund - Growth - Direct Plan is currently ₹1,383 Crores.

The Top three stocks are Sun Pharma Inds., Cipla and Divis Lab and account for 30% of its portfolio. Top 5 and 10 stocks of fund account for 40% and 58% of fund’s portfolio respectively.

Top three sectors of HDFC Pharma and Healthcare Fund - Growth - Direct Plan fund are Healthcare, Miscellaneous and accounting for 100% of the total portfolio.

Since this is a Equity - Sectoral Fund - Pharma & Health Care it is comparatively safer to invest in this fund. However, since it has not consistently outperformed its benchmark index on an average 3-year rolling returns basis it is not the most suitable fund for SIP.

The category of HDFC Pharma and Healthcare Fund - Growth - Direct Plan Fund is Equity - Sectoral Fund - Pharma & Health Care.

Nikhil Mathur manages the HDFC Pharma and Healthcare Fund - Growth - Direct Plan Fund.

HDFC Pharma and Healthcare Fund - Growth - Direct Plan current PE ratio is 47.48 and PB ratio is 6.88

The asset allocation of HDFC Pharma and Healthcare Fund - Growth - Direct Plan is Stocks : 99.23%, Debt : 0.77% and Gold : 0%

The minimum SIP amount for HDFC Pharma and Healthcare Fund - Growth - Direct Plan is ₹100.00 and minimum lumpsum is ₹100.00

The exit load for HDFC Pharma and Healthcare Fund - Growth - Direct Plan is 1% on or before 30 days, Nil after 30 days

© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.